Measurement of glycated proteins, especially haemoglobins, is now a routine procedure for monitoring previous glycaemic control in diabetic patients in the developed world. Until recently, however, the assays were sophisticated and costly and, therefore, were only rarely used in developing countries. With easier and cheaper tests now available, the measurement of glycaemic control could be also introduced into regional hospitals in developing countries. This paper reviews feasible methods for clinical laboratories with limited resources. Recent experiences from African countries are included.
Get full access to this article
View all access options for this article.
References
1.
KingHRewersM. Diabetes in adults is now a third world problem: The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ1991; 69: 643–8
2.
McLartyDGPolittCSwaiAB. Diabetes in Africa. Diabet Med.1990; 7: 670–84
3.
RolfeM. Diabetic renal disease in Central Africa. Diabet Med.1988; 5: 630–3
4.
McLartyDGKinaboLSwaiAB. Diabetes in tropical Africa: a prospective study 1981–87. Course and prognosis. BMJ1990; 300: 1107–10
5.
LesterF. Clinical status in Ethiopian diabetic patients after 20 years of diabetes. Diabet Med.1991; 8: 272–6
6.
KalkWJOsierCETaylorDPanzVR. Prior long-term glycaemic control and insulin therapy in insulin-dependent diabetic adolescent with microalbuminaria. Diabet Res Clin Pract1990; 9: 83–8
7.
AkanjiAOAgbedanaAOOgbodeC. Plasma lipid profiles in relation to diabetic control in Nigerians. Afr J Med Med Sci.1989; 18: 229–34
8.
AtabaniGSSaaedBOAl-MahdiEMAdamMEHassanDA. Glycated haemoglobin and other biochemical parameters in Sudanese diabetics. Ann Clin Biochem1989; 26: 32–4
9.
FamuyiwaOOAbanjiAOBellaAF. Haemoglobin A, levels in Nigerian diabetic patients using microcolumn affinity chromatography. Afr J Med Med Sci.1986; 15: 49–53
10.
Gebre-YohannesARahlenbeckSI. Glycaemic control and its determinants in diabetic patients in Ethiopia. Diabet Res Clin Pract1997; 35: 129–34
11.
ReiberGEKingH. Guidelines for the development of a national program for diabetes mellitus. Geneva: World Health Organization: 1991
12.
AtabaniGSAl-WhaliNMSaeedBOAl-MahdiMA. Effect of 75 g oral glucose on fructosamine and glycated haemoglobin concentrations. Ann Clin Biochem1990; 27: 270–1
13.
RaoGMMorghomLOAbukhrisAAMansoriSSRagaleLY. Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients. Trop Geogr Med.1986; 38: 391–7
14.
PrendergastCSmythOMurrayFCunninghamSKMcKennaTJ. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects. Ir J Med Sci.1994; 163: 233–5
15.
NathanJMSingerDEHurxthalKGoodsonJD. The clinical information value of glycosylated hemoglobin assay. New Engl J Med.1984; 310: 341–6
16.
BunnHGGabbayKHGaloppPM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science1978; 200: 21–7
17.
LittleRRWiedmeyerHMEnglandJDNaitoHKGoldsteinDE. Interlaboratory comparison of glycohemoglobin results: College of American Pathologists survey data. Clin Chem1991; 37: 1725–9
18.
TaharaYShimaK. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose levels. Diabetes Care1995; 18: 440–7
19.
JamesTMDavisJEMcDonaldJMSantiagoJVLadensenJH. Comparison of hemoglobin A1c and hemoglobin A1 in diabetic patients. Clin Biochem1981; 14: 25–7
LittleRREnglandJDWiedmeyerHMGoldsteinDE. Effects of whole blood storage on results for glycosylated hemoglobin as measured by ion-exchange chromatography, affinity chromatography and colorimetry. Clin Chem1983; 29: 1113–15
22.
MortensenHBNielsenLSoegaardUSvendsenPANerupJ. Comparison of six assays for glycated haemoglobin determination. Scand J Clin Lab Invest1993; 43: 357–62
23.
BodorGSLittleRRGarettNBrownWGoldsteinDENahmMH. Standardization of glycohemoglobin determinations in the clinical laboratory. Clin Chem1992; 38: 2414–18
24.
WeykampCWPendersTJMuskietFAvan der SilkW. Glycohaemoglobin: a comparison of 12 analytical methods, applied to lyophilized haemolysates by 101 laboratories in an external quality assurance programme. Ann Clin Biochem1993; 30: 169–174
25.
JohnWG. Glycated haemoglobin analysis. Ann Clin Chem Biochem1997; 34: 17–31
26.
EngbaekFChristensenSEJespersenB. Enzyme immunoassay of hemoglobin Alc: analytical characteristics and clinical performance for patients with diabetes mellitus, with and without uremia. Clin Chem1989; 35: 93–7
27.
MiedemaK. Influence of hemoglobin variants on the determination of glycated hemoglobins. Clin Lab1993; 39: 1029–32
28.
AllenLC. Effect of hemoglobin variants on HbA1c determinations using Bio-Rad columns. Clin Chem1985; 18: 173–5
29.
ReidHLFamoduAAPhotiadesOPOsamoON. Glycated haemoglobin HbAlc and HbSc in non-diabetic Nigerians. Trop Geogr Med.1992; 44: 126–30
30.
KilpatrickESRumleyAGDominiczakMHSmallK. Glycated hemoglobin values: problems in assessing glucose control in diabetes mellitus. BMJ1994; 309: 983–6
31.
JohnGWGrayMRBatesDLBeachamJL. Enzyme immunoassay — a new technique for estimating hemoglobin A1c. Clin Chem1993; 39: 663–6
32.
NgRHSparksKMHiarCE. A rapid automated immunoassay for measuring hemoglobin A1c using pre-calibrated unitized reagent cartridges. Clin Chem1992; 38: 234–45
33.
RumleyAGKilpatrickESDominiczakMHSmallM. Evaluation of glycaemic control limits using the Ames DC 2000 HbA1c analyzer. Diabet Med.1993; 10: 976–9
34.
EatonSEFeldenSEHuismanP. Glycated haemoglobin (HbAlc) measurements in subjects with haemoglobin variants, using the DCA 2000. Ann Clin Biochem1997; 34: 205–7
35.
TurpeinenUKarjaleinenUStenmanUH. Three assays for glycohemoglobin compared. Clin Chem1995; 41: 191–5
36.
CampagnucciPCartechiniMGBolliGde FeoPSanteusFBrunettiP. The importance of determining irreversibly glycosylated hemoglobin in diabetics. Diabetes1981; 30: 607–17
37.
GomoZA. The determination of glucose and glycosylated haemoglobins in a non-diabetic Zimbabwean African population. Ann Clin Biochem1985; 22: 362–5
38.
JumaFDGitauWGachokaC. The use of HbA1c in evaluation of diabetic control in Kenya Africans. East Afr Med J1983; 60: 60–3
39.
MengistuM. The use of haemoglobin A1 in the evaluation of diabetic control in adult Ethiopian diabetics. Ethiop Med J1988; 26: 127–31
40.
OnyemelukweGCIsahHSMbaECAwunnar-RennerCMohamedI. Glycosylated hemoglobin (HbA1) for diabetic control in Africans: preliminary findings with the microcolumn technique. Trop Geogr Med.1983; 35: 347–51
41.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development on long-term complications in insulin-dependent diabetes mellitus. New Eng J Med.1993; 329: 977–86
42.
KleinRKleinBEMossSECruickshanksK. Relationship of hyperglycaemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med.1994; 154: 2169–78
43.
GilbertRETsalamandrisCBachLA, Long-term control and the rate of progression of early diabetes kidney disease. Kidney Int.1993; 44: 855–9
44.
AlbertiKGGriesFA. Management of non-insulin dependent diabetes mellitus in Europe: a consensus view. Diabet Med.1988; 5: 275–81
45.
European IDDM Policy Group. Consensus guidelines for the management of insulin-dependent (type 1) diabetes. Diabet Med.1993; 10: 990–1005
46.
Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycaemia in the Diabetes Control and Complications Trial. Am J Med.1991; 90: 450–9
JohnsonRNMetcalfPABakerJR. Fructosamine: a new approach to the estimation of serum glycoprotein. An index of diabetic control. Clin Chem1983; 127: 87–95
49.
MoscaACareniniAZoppiF, Plasma protein glycation as measured by fructosamine assay. Clin Chem1987; 33: 1141–6
50.
JuryDRDunnP. Laboratory assessment of a commercial kit for measuring fructosamine in serum. Clin Chem1987; 33: 158–61
51.
Rodriguez-SegadeSLojoSCaminaMFPazMDel RioR. Effects of various serum proteins on quantification of fructosamine. Clin Chem1989; 35: 134–8
52.
HennyJSchieleF. Age-dependence, sex-dependence, and reference values of serum fructosamine determined by a new colorimetric method. Wien Klin Wschr1990; 102 (suppl): S47–s51
53.
GomoZA. Serum fructosamine: a parameter for monitoring control in diabetes. Centr Afr Med J1992; 38: 358–61
54.
SinghJKuligKA. Effects of albumin and immunoglobulin A on fructosamine assay. Clin Chem1992; 38: 824–30
55.
BakerJRMetcalfPAHoldawayAMJohnsonRN. Serum fructosamine concentration as a measure of blood glucose in type I diabetes mellitus. BMJ1985; 290: 352–5
56.
HindleEJRostronGMGattJA. The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin. Ann Clin Biochem1985; 22: 84–9
57.
SwaiABHarrisonKChuwaLMMakeneWMcCartyDAlbertiKG. Screening for diabetes. Does measurement of serum fructosamine help?Diabet Med.1988; 5: 648–52
58.
ElwaliNM Saeed BOAtabaniGSElmahdiEMMukhtarE. The use of plasma fructosamine in the assessment of diabetic control. Trop Geogr Med.1991; 43: 51–4
59.
BakerJRJohnsonRNScottDJ. Serum fructosamine concentrations in patients with type II diabetes mellitus during changes in management. BMJ1984; 288: 1484–6
60.
LloydOMarplesJ. Serum fructosamine and thyroid function. Clin Chem1986; 32: 1985–9
